Oriola Oyj
ISIN: FI0009014344 | Ticker: OKDAV | LEI: 549300UWB1AIR85BM957
Country: Finland
Oriola is a health and wellbeing company operating in Finland and Sweden. We help people to lead healthier lives by giving them access to sustainable health and wellbeing products and services. Our supply chain ensures reliable and safe delivery of pharmaceuticals to pharmacies, hospital pharmacies, veterinarians and other healthcare operators and our expert services support pharmaceutical companies throughout the entire lifecycle of medicines.
The safety and effectiveness of pharmaceutical care is supported by our dose-dispensing, medical information, and patient support services. In 2021, Oriola Corporation’s net sales were 1.9 billion euros and we employed approximately 4,100 professionals. Oriola Corporation is listed on Nasdaq Helsinki.
1907
Headcount4,100
HeadquartersOrionintie 5, 2200 Espoo – Finland
| Line item in (eur) | 02.01.2019 | 01.01.2020 | 02.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|
| Assets | N/A | 1,030,600,000.00 | N/A | 1,165,600,000.00 | 1,093,200,000.00 | 960,900,000.00 |
| Noncurrent Assets | N/A | 509,900,000.00 | N/A | 537,300,000.00 | 539,300,000.00 | 419,100,000.00 |
| Property Plant And Equipment | N/A | 158,300,000.00 | N/A | 162,200,000.00 | 155,900,000.00 | 57,700,000.00 |
| Goodwill | N/A | 270,500,000.00 | N/A | 278,700,000.00 | 273,500,000.00 | 61,100,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 66,900,000.00 | N/A | 69,800,000.00 | 71,000,000.00 | 20,600,000.00 |
| Investments In Joint Ventures Accounted For Using Equity Method | N/A | N/A | N/A | N/A | 0.00 | 240,400,000.00 |
| Deferred Tax Assets | N/A | 4,500,000.00 | N/A | 4,400,000.00 | 3,900,000.00 | 1,200,000.00 |
| Other Noncurrent Financial Assets | N/A | 9,700,000.00 | N/A | 22,300,000.00 | 34,900,000.00 | 38,300,000.00 |
| Current Assets | N/A | 520,700,000.00 | N/A | 628,300,000.00 | 553,900,000.00 | 541,800,000.00 |
| Current Trade Receivables | N/A | 187,400,000.00 | N/A | 188,600,000.00 | 194,700,000.00 | 226,800,000.00 |
| Other Current Receivables | N/A | 22,200,000.00 | N/A | 18,100,000.00 | 18,200,000.00 | 4,700,000.00 |
| Cash and cash equivalents | 65,800,000.00 | 70,800,000.00 | 70,800,000.00 | 168,200,000.00 | 109,100,000.00 | 160,600,000.00 |
| Equity And Liabilities | N/A | 1,030,600,000.00 | N/A | 1,165,600,000.00 | 1,093,200,000.00 | 960,900,000.00 |
| Equity | N/A | 157,200,000.00 | N/A | 169,600,000.00 | 216,800,000.00 | 225,600,000.00 |
| Issued Capital | N/A | 36,200,000.00 | N/A | 36,200,000.00 | 36,200,000.00 | 36,200,000.00 |
| Retained Earnings | N/A | 59,700,000.00 | N/A | 54,500,000.00 | 88,300,000.00 | 83,200,000.00 |
| Other Reserves | N/A | 100,000.00 | N/A | 100,000.00 | 100,000.00 | 100,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 157,200,000.00 | N/A | 169,600,000.00 | 216,800,000.00 | 225,600,000.00 |
| Noncurrent Liabilities | N/A | 155,700,000.00 | N/A | 161,600,000.00 | 153,800,000.00 | 87,300,000.00 |
| Deferred Tax Liabilities | N/A | 14,300,000.00 | N/A | 13,900,000.00 | 11,800,000.00 | 4,900,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 17,100,000.00 | N/A | 18,900,000.00 | 18,000,000.00 | 11,800,000.00 |
| Other Noncurrent Liabilities | N/A | 700,000.00 | N/A | 900,000.00 | 500,000.00 | 700,000.00 |
| Current Liabilities | N/A | 717,700,000.00 | N/A | 834,500,000.00 | 722,600,000.00 | 648,000,000.00 |
| Current Tax Liabilities Current | N/A | 1,000,000.00 | N/A | 0.00 | 1,400,000.00 | 1,000,000.00 |
| Other Current Liabilities | N/A | 40,400,000.00 | N/A | 45,900,000.00 | 43,100,000.00 | 22,800,000.00 |
| Line item in (eur) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue | 1,721,300,000.00 | 1,800,800,000.00 | 1,452,200,000.00 | 1,515,500,000.00 |
| Other Income | 11,100,000.00 | 9,500,000.00 | 4,500,000.00 | 5,800,000.00 |
| Employee Benefits Expense | 173,400,000.00 | 172,300,000.00 | 71,900,000.00 | 61,100,000.00 |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 45,300,000.00 | 41,600,000.00 | 16,500,000.00 | 25,200,000.00 |
| Other Expense By Nature | 133,900,000.00 | 137,200,000.00 | 92,600,000.00 | 95,900,000.00 |
| Profit Loss From Operating Activities | 15,300,000.00 | 20,400,000.00 | 10,700,000.00 | 7,600,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | N/A | N/A | 0.00 | -2,000,000.00 |
| Profit Loss Before Tax | 10,100,000.00 | 14,300,000.00 | 11,000,000.00 | 6,900,000.00 |
| Income Tax Expense Continuing Operations | 2,100,000.00 | 3,100,000.00 | 2,300,000.00 | 2,100,000.00 |
| Profit Loss From Continuing Operations | N/A | N/A | 8,600,000.00 | 4,800,000.00 |
| Profit Loss From Discontinued Operations | N/A | N/A | 2,700,000.00 | -7,200,000.00 |
| Profit (loss) | 8,000,000.00 | 11,300,000.00 | 11,300,000.00 | -2,400,000.00 |
| Profit Loss Attributable To Owners Of Parent | 8,000,000.00 | 11,300,000.00 | 11,300,000.00 | -2,400,000.00 |
| Line item in (eur) | 01.01.2020 | 02.01.2019 | 01.01.2021 | 02.01.2020 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|
| Profit (loss) | 8,000,000.00 | N/A | 11,300,000.00 | N/A | 11,300,000.00 | -2,400,000.00 |
| Adjustments For Income Tax Expense | 2,100,000.00 | N/A | 3,100,000.00 | N/A | 3,400,000.00 | 7,900,000.00 |
| Adjustments For Decrease Increase In Inventories | -27,200,000.00 | N/A | -8,600,000.00 | N/A | 17,300,000.00 | 10,800,000.00 |
| Adjustments For Depreciation And Amortisation Expense | 41,800,000.00 | N/A | 41,200,000.00 | N/A | 43,100,000.00 | 18,300,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 3,500,000.00 | N/A | 500,000.00 | N/A | 1,800,000.00 | 9,800,000.00 |
| Other Adjustments For Noncash Items | 1,000,000.00 | N/A | -2,000,000.00 | N/A | -700,000.00 | -1,300,000.00 |
| Cash Flows From Used In Operating Activities | 84,400,000.00 | N/A | 58,300,000.00 | N/A | 40,000,000.00 | 77,900,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | N/A | N/A | 0.00 | 3,200,000.00 |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | N/A | N/A | N/A | N/A | 0.00 | -24,300,000.00 |
| Proceeds From Other Longterm Assets Classified As Investing Activities | 0.00 | N/A | 200,000.00 | N/A | 32,800,000.00 | 0.00 |
| Cash Flows From Used In Investing Activities | -21,800,000.00 | N/A | -31,400,000.00 | N/A | 9,600,000.00 | 3,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | 100,000.00 | N/A | 100,000.00 | N/A | 100,000.00 | 100,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 19,300,000.00 | N/A | 19,600,000.00 | N/A | 21,200,000.00 | 15,700,000.00 |
| Dividends Paid Classified As Financing Activities | 16,300,000.00 | N/A | 16,300,000.00 | N/A | 5,400,000.00 | 7,300,000.00 |
| Cash Flows From Used In Financing Activities | -57,600,000.00 | N/A | 70,400,000.00 | N/A | -108,500,000.00 | -29,300,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 0.00 | N/A | 100,000.00 | N/A | 0.00 | -100,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 5,000,000.00 | N/A | 97,300,000.00 | N/A | -59,000,000.00 | 51,600,000.00 |
| Cash and cash equivalents | 70,800,000.00 | 65,800,000.00 | 168,200,000.00 | 70,800,000.00 | 109,100,000.00 | 160,600,000.00 |
Please note that some sums might not add up.
FI0009014344
LEI549300UWB1AIR85BM957
SectorConsumer Staples Distribution & Retail
IndustryConsumer Staples Distribution & Retail
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.